Application Information

This drug has been submitted to the FDA under the reference 021629/001.

Names and composition

"APIDRA" is the commercial name of a drug composed of INSULIN GLULISINE RECOMBINANT.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021629/001 APIDRA INSULIN GLULISINE RECOMBINANT INJECTABLE/IV (INFUSION), SUBCUTANEOUS 1000 UNITS per 10ML (100 UNITS per ML)
021629/002 APIDRA INSULIN GLULISINE RECOMBINANT INJECTABLE/IV (INFUSION), SUBCUTANEOUS 300 UNITS per 3ML (100 UNITS per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021629/001 APIDRA INSULIN GLULISINE RECOMBINANT INJECTABLE/IV (INFUSION), SUBCUTANEOUS 1000 UNITS per 10ML (100 UNITS per ML)
021629/002 APIDRA INSULIN GLULISINE RECOMBINANT INJECTABLE/IV (INFUSION), SUBCUTANEOUS 300 UNITS per 3ML (100 UNITS per ML)
021629/003 APIDRA SOLOSTAR INSULIN GLULISINE RECOMBINANT INJECTABLE/SUBCUTANEOUS 300 UNITS per 3ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved